SCHEMBL5483895

SCHEMBL5483895

COc1ccc2c(oc3ccc(C#N)cc32)c1C1CCCC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HRH4 Q9H3N8 1/20 0.37
▸ PTGDR2 Q9Y5Y4 1/20 0.37
▸ CCNT1 O60563 1/20 0.35
▸ CDK9 P50750 1/20 0.35
▸ KDM1A O60341 1/20 0.35
▸ CYP11B2 P19099 2/20 0.35
▸ AR P10275 3/20 0.34
▸ PDE5A O76074 2/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ MAPK7 Q13164 1/20 0.34
▸ HCRTR1 O43613 1/20 0.34
▸ HCRTR2 O43614 1/20 0.34
▸ HTR2A P28223 1/20 0.33
▸ LRRK2 Q5S007 1/20 0.33
▸ PDE4A P27815 1/20 0.33
▸ PDE4B Q07343 1/20 0.33
▸ PDE4C Q08493 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5477167 0.82 HRH4 (0.36) HRH4PTGDR2KDM1AARLRRK2
SCHEMBL5477181 0.76 PDE5A (0.38) HRH4ARPDE5ANPC1RAB9A
SCHEMBL13564574 0.73 CYP2A6 (0.44) HRH4
SCHEMBL5472664 0.72 PDE5A (0.36) ARPDE5AMEN1RAB9AKMT2A
SCHEMBL5471189 0.67 AR (0.40) ARMEN1NPC1RAB9AKMT2A
SCHEMBL1260698 0.67 DRD3 (0.35) PTGDR2LRRK2
SCHEMBL7335983 0.67 F2 (0.63) KDM1AARPDE5ALRRK2PDE4D
SCHEMBL548410 0.67 CYP2A6 (0.50) MEN1NPC1RAB9AKMT2A
SCHEMBL5468128 0.66 MAPT (0.53) ARMEN1NPC1RAB9AKMT2A
SCHEMBL5022989 0.66 PDE4A (0.44) MEN1NPC1RAB9AKMT2APDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070093548-A1 Use of progesterone receptor modulators WYETH (US) 2007-04-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070093548-A1 Use of progesterone receptor modulators PGR, GNRHR, PGRMC2 HRH4 1091/4885PTGDR2 28/4885CCNT1 1253/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback